Life Sciences

Marlborough company Sunovion Pharmaceuticals Inc. has begun its in-human clinical trials for a drug to treat generalized anxiety disorder.

Spheric Bio, a Cambridge company developing a 3D heart implant to help prevent strokes, was awarded $50,000 for winning the M2D2 Challenge, a partnership between UMass Chan Medical School and UMass Lowell.

Precision Optics Corp., Inc., in Gardner announced the appointment of Mahesh Lawande in the newly created role of chief operating officer.

The sciences companies in Central Massachusetts that received venture capital funding from 2018 to 2023.

Large for-profit life sciences companies have called Central Mass. their home for decades. Now, they play an important role in bringing talent, investment, and research to the region.

Researchers across Central Mass. are leading development of cutting-edge ideas and therapies to provide the next generation of solutions to present and future problems.

Space and cost issues have begun to creep into Cambridge and Boston, forcing companies, especially startups, to look outside of the Route 128 belt and increasingly more towards Central Massachusetts.

The Massachusetts Biotechnology Council rates the state’s various communities as BioReady based on their ability to host biotechnology facilities.

Developers and brokers are using multiple strategies to bring life sciences companies out past Route 128 in Massachusetts.

Biostage, a cell-therapy biotech company based in Holliston, has received $6 million in commitments from investors to accelerate its clinical development program.